TABLE 2.

Characteristics of patients included in the mortality analysis cohort

Study	Country	Outcome	Sample Size	Non-survivors				Survivors
				n (%)	Age (yrs)*	Women (%)	CVD n (%)	n (%)	Age (yrs)*	Women (%)	CVD n (%)
Deng et al. (2020)	Wuhan, China	In-hospital mortality	225	109 (48.5%)	69 (62-74)	36 (33%)	13 (11.9%)	116 (51.5%)	40 (33-57)	65 (56%)	4 (3.4%)
Ruan et al. (2020)	Wuhan, China	In-hospital mortality	150	68 (45.3%)	67 (15-81)	19 (28%)	13 (19%)	82 (54.6%)	50 (44-81)	29 (35%)	0 (0%)
Wu et al. (2020)	Wuhan, China	In-hospital mortality	84	44 (52.3%)	68.5 (59.3-75)	15 (34.1%)	4 (9.1%)	40 (47.7%)	50 (40.3-56.8)	9 (22,5%)	4 (10%)
Yang et al. (2020)	Wuhan, China	28-day mortality after ICU admission	52	32 (61.5%)	64.6 (11.2)	11 (34%)	3 (9%)	20 (38.5%)	51.9 (12.9)	6 (30%)	2 (10%)
Zhou et al. (2020)	Wuhan, China	In-hospital mortality or discharge	191	54 (28.3%)	69 (63-76)	16 (30%)	13 (24%)	137 (71.7%)	52 (45-58)	56 (41%)	2 (1%)
Wang Y et al. (2020)	Shanghai, China	28-day mortality after ICU admission	334	211	69 (62-74)	36 (33%)	13 (11.9%)	133 (34.7%)	40 (33-57)	65 (56%)	4 (3.4%)